Contraindicated (one)bortezomib will raise the level or result of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Robust or average CYP2C19 inhibitors may enhance mavacamten systemic publicity, leading to coronary heart failure because of systolic dysfunction. The sq. root of two will be the frequency ratio of a tritone interval https://gregoryxpbnu.digiblogbox.com/52300090/indicators-on-thalicarpine-you-should-know